Ivan Staykov

692 total citations
5 papers, 295 citations indexed

About

Ivan Staykov is a scholar working on Immunology, Pediatrics, Perinatology and Child Health and Rheumatology. According to data from OpenAlex, Ivan Staykov has authored 5 papers receiving a total of 295 indexed citations (citations by other indexed papers that have themselves been cited), including 5 papers in Immunology, 3 papers in Pediatrics, Perinatology and Child Health and 3 papers in Rheumatology. Recurrent topics in Ivan Staykov's work include Biosimilars and Bioanalytical Methods (5 papers), Rheumatoid Arthritis Research and Therapies (3 papers) and Pharmaceutical studies and practices (3 papers). Ivan Staykov is often cited by papers focused on Biosimilars and Bioanalytical Methods (5 papers), Rheumatoid Arthritis Research and Therapies (3 papers) and Pharmaceutical studies and practices (3 papers). Ivan Staykov collaborates with scholars based in Austria, South Korea and Lithuania. Ivan Staykov's co-authors include Asta Baranauskaitė, Hana Ciferská, Josef S Smolen, Eva Dokoupilová, Roman Yatsyshyn, Mevludin Mekić, Nenad Prodanović, Krystyna Jedrychowicz‐Rosiak, Young Hee Rho and Jung‐Yoon Choe and has published in prestigious journals such as Annals of the Rheumatic Diseases and Lara D. Veeken.

In The Last Decade

Ivan Staykov

5 papers receiving 294 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Ivan Staykov Austria 5 264 108 106 104 48 5 295
Jaroslaw Niebrzydowski South Korea 6 367 1.4× 147 1.4× 159 1.5× 148 1.4× 61 1.3× 8 410
Vladimir Kadinov Bulgaria 5 419 1.6× 148 1.4× 135 1.3× 191 1.8× 91 1.9× 6 453
Krystyna Jedrychowicz‐Rosiak South Korea 8 464 1.8× 180 1.7× 210 2.0× 190 1.8× 76 1.6× 10 525
Jeehoon Ghil South Korea 9 546 2.1× 219 2.0× 259 2.4× 287 2.8× 36 0.8× 23 618
Gaurav Rathi United States 6 98 0.4× 27 0.3× 26 0.2× 50 0.5× 16 0.3× 9 150
Véronique Lamarque France 3 190 0.7× 21 0.2× 19 0.2× 56 0.5× 45 0.9× 7 288
Johanna Elin Gehin Norway 8 101 0.4× 7 0.1× 19 0.2× 98 0.9× 25 0.5× 29 197
Lucy M. Han United States 8 52 0.2× 18 0.2× 18 0.2× 28 0.3× 15 0.3× 13 160
Kathrine Lederballe Grøn Denmark 7 72 0.3× 12 0.1× 11 0.1× 117 1.1× 14 0.3× 14 161
Anna Gimigliano Italy 5 23 0.1× 85 0.8× 8 0.1× 16 0.2× 79 1.6× 8 270

Countries citing papers authored by Ivan Staykov

Since Specialization
Citations

This map shows the geographic impact of Ivan Staykov's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ivan Staykov with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ivan Staykov more than expected).

Fields of papers citing papers by Ivan Staykov

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Ivan Staykov. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ivan Staykov. The network helps show where Ivan Staykov may publish in the future.

Co-authorship network of co-authors of Ivan Staykov

This figure shows the co-authorship network connecting the top 25 collaborators of Ivan Staykov. A scholar is included among the top collaborators of Ivan Staykov based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Ivan Staykov. Ivan Staykov is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

5 of 5 papers shown
1.
2.
Smolen, Josef S, Jung‐Yoon Choe, Nenad Prodanović, et al.. (2017). Comparing biosimilar SB2 with reference infliximab after 54 weeks of a double-blind trial: clinical, structural and safety results. Lara D. Veeken. 56(10). 1771–1779. 44 indexed citations
3.
4.
Choe, Jung‐Yoon, Nenad Prodanović, Jaroslaw Niebrzydowski, et al.. (2015). A randomised, double-blind, phase III study comparing SB2, an infliximab biosimilar, to the infliximab reference product Remicade in patients with moderate to severe rheumatoid arthritis despite methotrexate therapy. Annals of the Rheumatic Diseases. 76(1). 58–64. 138 indexed citations
5.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Jaroslaw Niebrzydowski Breakdown of academic impact, for papers by Vladimir Kadinov Breakdown of academic impact, for papers by Krystyna Jedrychowicz‐Rosiak Breakdown of academic impact, for papers by Jeehoon Ghil Breakdown of academic impact, for papers by Gaurav Rathi Breakdown of academic impact, for papers by Véronique Lamarque Breakdown of academic impact, for papers by Johanna Elin Gehin Breakdown of academic impact, for papers by Lucy M. Han Breakdown of academic impact, for papers by Kathrine Lederballe Grøn Breakdown of academic impact, for papers by Anna Gimigliano
Rankless by CCL
2026